About us

We develop technology for improving the care and life quality of our most vulnerable patients – preterm born infants.

A word from Hanna Sjöström CEO

GPX Medical has set the foundation towards commercialization of a unique medical device for lung monitoring of preterm born babies, with great potential on the Global market for neonatal care. With our innovation we are able to improve the care of our most vulnerable patients. Would you like to join our journey as neonatologist collaborating in clinical studies, industry partner or investor? Please do contact me.

Kind regards,

Hanna Sjöström

CEO, GPX Medical AB

Email: hs@gpxmedical.se
Mobile: +46 (0)760 107116

Hanna Sjöström

Hanna Sjöström

CEO

The Board

Märta Lewander Xu


Märta Lewander Xu


PhD
Chariman GPX Medical 
CEO Gasporox AB

Tore Gimse

Tore Gimse

Chairman Gasporox AB
CEO Norsk Elektro Optikk AS

Katarina Svanberg

Katarina Svanberg

MD, PhD
Professor of Oncology
Lund University Hospital

 

Stephan Dymling

Stephan Dymling

CTO CLS AB
CTO, member of board,
BiBB Instrument
 AB

For Investors

GPX Medical is on a journey to create better care for for our most vulnerable patients.

About GPX Medical

GPX Medical AB was formed in 2016 as a subsidiary to Gasporox AB (publ) with the aim to develop and commercialize medical applications of the GASMAS technology. The company is owned by Gasporox AB (publ) to 53,3%, by Norsk Elektro Optikk AS to 36,2% and by the team to 10,5%. The company is located in Lund, Sweden. Org. nbr. 559069-9012.

For investors

Please contact CEO Hanna Sjöström for investment opportunities:
hs@gpxmedical.se

Contact

GPX Medical AB
Maskinvägen 1
227 30 Lund
Sweden
info@gpxmedical.se